Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Sera Prognostics (NASDAQ:SERA) through any online brokerage.
Other companies in Sera Prognostics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Sera Prognostics has a consensus price target of $6.00.
The stock price for Sera Prognostics (NASDAQ: SERA) is $1.92 last updated August 11, 2026 at 9:25 AM EDT.
There are no upcoming dividends for Sera Prognostics.
Sera Prognostics does not have any upcoming earnings scheduled.
There is no upcoming split for Sera Prognostics.
Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.